3
Announcements
Trials
Browse
Landscape
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Sarcoma
1
Head & Neck
1
Gynecologic
1
Genitourinary
1
Gastrointestinal
1
Breast
1
Conditions
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Sarcoma
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Lung Neoplasms
1
Liver Neoplasms
1
Head and Neck Neoplasms
1
Colonic Neoplasms
1
Breast Neoplasms
1
Anus Neoplasms
1
Interventions
Nivolumab
3
Specimen Handling
2
Magnetic Resonance Spectroscopy
2
Biopsy
2
trastuzumab deruxtecan
1
X-Rays
1
Watchful Waiting
1
Tomography, X-Ray Computed
1
Taxes
1
Sigmoidoscopy
1
Radionuclide Imaging
1
Proctoscopy
1
Phantoms, Imaging
1
Paclitaxel
1
Observation
1
Mn(III) meso-tetrakis(N-n-butoxyethylpyridinium-2-yl)porphyrin
1
Magnetic Resonance Imaging
1
Ipilimumab
1
Ibuprofen
1
Epinephrine
1
Electrocardiography
1
Diphenhydramine
1
Dexamethasone
1
Colonoscopy
1
Carboplatin
1
Calcium Dobesilate
1
CTLA-4 Antigen
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Anus Neoplasms
×
Radionuclide Imaging
×
30 days
×
Clear all
NCT06904365
2026-05-18
OvAR-Y
Washington University School of Medicine
Active not recruiting
10 enrolled